Uniphar PLC - AGM Results

AGM Results
Uniphar plc (the Company) announces that at its Annual General Meeting ("AGM") held at
Details of votes cast are set out below:
|
|
RESOLUTION |
For |
For % |
Against |
Against % |
Withheld |
|
1 |
Financial Statements and Reports |
155,801,328 |
100.00% |
- |
0.00% |
65,198 |
|
2 |
Final Dividend of |
155,862,330 |
100.00% |
4,196 |
0.00% |
- |
|
3(a) |
Re-elect Ger Rabbette |
155,170,281 |
99.57% |
662,597 |
0.43% |
33,648 |
|
3(b) |
Re-elect Tim Dolphin |
155,132,752 |
99.55% |
700,126 |
0.45% |
33,648 |
|
3(c) |
Re-elect Paul Hogan |
154,475,082 |
99.11% |
1,391,444 |
0.89% |
- |
|
3(d) |
Re-elect Sue Webb |
153,396,166 |
98.44% |
2,436,712 |
1.56% |
33,648 |
|
3(e) |
Re-elect Jim Gaul |
143,860,681 |
92.32% |
11,972,197 |
7.68% |
33,648 |
|
3(f) |
Re-elect Liz Hoctor |
155,516,769 |
99.78% |
349,757 |
0.22% |
- |
|
3(g) |
Re-elect Maurice Pratt |
149,269,506 |
95.78% |
6,569,125 |
4.22% |
- |
|
3(h) |
Re-elect Valerie Sick |
154,441,434 |
99.11% |
1,391,444 |
0.89% |
33,648 |
|
4 |
Remuneration of Auditors |
132,756,119 |
85.17% |
23,109,607 |
14.83% |
800 |
|
5 |
Authority to allot relevant securities |
125,718,359 |
80.66% |
30,148,167 |
19.34% |
- |
|
6 |
Disapplication of pre- emption rights in specified circumstances |
155,282,158 |
99.63% |
583,568 |
0.37% |
800 |
|
7 |
Disapplication of pre- emption rights in additional Circumstances* |
103,983,762 |
66.71% |
51,882,764 |
33.29% |
- |
|
8 |
Authorise market purchases of the Company's Ordinary Shares |
155,455,359 |
100.00% |
- |
0.00% |
411,167 |
|
9 |
Re-issuance of Treasury Shares |
155,866,526 |
100.00% |
- |
0.00% |
- |
*The Board notes that Resolution 7, relating to the dis-application of pre-emption rights in certain additional circumstances, was not passed at the AGM. Resolution 7 was proposed on terms consistent with the Statement of Principles on Disapplying Pre-emption Rights published by the Pre-emption Group in
--- ENDS ---
Contact details
|
Uniphar Group
|
Tel: +353 (0) 1 428 7777 |
|
|
|
|
|
|
|
Davy (Joint Corporate Broker, Nominated Advisor and Euronext Growth Listing Sponsor)
|
Tel: +353 (0) 1 679 6363 |
|
|
|
|
|
|
|
RBC Capital Markets (Joint Corporate Broker)
|
Tel: +44 (0) 20 7653 4000 |
|
|
|
|
|
|
|
Stifel Nicolaus Europe Limited (Joint Corporate Broker)
|
Tel: +44 (0) 20 7710 7600 |
|
|
|
|
|
|
|
Q4 PR
|
Tel: +353 (0) 1 475 1444 |
|
|
|
About Uniphar plc
Headquartered in
The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar represents a strong combination of scale, growth, and profitability.
Uniphar Supply Chain & Retail
Uniphar Supply Chain & Retail is the leading pharmaceutical wholesaler in
Uniphar Medtech
Uniphar Medtech is a leading Pan-European medical device distributor and solutions partner. The Group's strategy for Uniphar Medtech is to grow our service offering across
Uniphar Pharma
Uniphar Pharma operates a global business with high value services across the lifecycle of a pharmaceutical product. We enable pharma and biotech companies to bring innovative medicines to global markets and provide healthcare professionals with access to medicines they can't source through traditional channels. Our strategy is to build a leading platform to provide the specialist support and expertise needed to improve access to these medicines.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) and this website (the Site) on the terms set out in this disclaimer, together with all other terms and conditions, disclaimers and other notices displayed elsewhere on this Site.
It is important for you to know that:
(a) none of the Content is, or is intended to be, general or personal advice
(b) the principal purpose of the Content is to provide factual information only and to comment on news;
(c) the Content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including in respect of any particular security, portfolio of securities, transaction or investment strategy, and must not be relied upon by you as such;
(d) in providing you with the Content, we have not considered your objectives, financial situation or needs; and
(e) you should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
The Content contains data (including but not limited to prices, statistics and calculated information) obtained from a variety of third party sources (Third Party Data). The Company does not make any representation or warranty that any of the Content, including the Third Party Data, will be reliable, accurate or complete. The Company disclaims all responsibility and liability arising in any way from any errors or omissions in the Content, including the Third Party Data, including any loss you may incur in connection with any action or decision made by you in reliance upon the Content or Third Party Data.
In certain circumstances the Company, its related bodies corporate, or their affiliates, may have received, or be entitled to receive, financial or other consideration in connection with providing information about certain entities on the Site, which may include the above Content.
FOR OUR FULL DISCLAIMER CLICK HERE